Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Pfizer, inc. symbols : Opk save search
FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
Published: 2023-06-28 (Crawled : 11:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.22%
H: 0.11%
C: -0.58%
OPK | $1.23 0.0% 2.7M
|
Health Technology
|
| O: 24.1%
H: 0.97%
C: -16.5%
fda treatment growth hormone
Pfizer Reports First-Quarter 2022 Results
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 1.77%
H: 2.39%
C: 0.86%
BHVN | News 0 d | $38.99 -7.52% 0.0% 3.4M
|
Health Technology
|
| O: 4.37%
H: 0.98%
C: -3.34%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: 7.97%
H: 2.91%
C: 0.0%
OPK | $1.23 0.0% 2.7M
|
Health Technology
|
| O: 2.94%
H: 4.64%
C: 3.21%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 3.06%
H: 3.6%
C: 2.08%
BEAM | $23.9 -1.69% -1.72% 4.5M
|
Health Technology
|
| O: 8.78%
H: 3.69%
C: -2.08%
results
Pfizer Reports Fourth-Quarter and Full-Year 2021 Results
Published: 2022-02-08 (Crawled : 12:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.07%
H: 0.44%
C: -0.2%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -4.81%
H: 2.29%
C: 2.09%
BHVN | News 0 d | $38.99 -7.52% 0.0% 3.4M
|
Health Technology
|
| O: -2.75%
H: 3.07%
C: 2.01%
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: 0.35%
H: 1.32%
C: -0.88%
OPK | $1.23 0.0% 2.7M
|
Health Technology
|
| O: 0.31%
H: 0.31%
C: -2.15%
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 2.98%
H: 3.02%
C: 1.52%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -7.54%
H: 2.13%
C: -1.69%
BEAM | $23.9 -1.69% -1.72% 4.5M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
report results
Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency
Published: 2021-09-24 (Crawled : 21:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
| Email alert
Add to watchlist
OPK | $1.23 0.0% 2.7M
|
Health Technology
| Email alert
Add to watchlist
fda growth hormone license growth hormone application
EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency
Published: 2021-02-26 (Crawled : 14:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.06%
H: 0.18%
C: -1.03%
OPK | $1.23 0.0% 2.7M
|
Health Technology
|
| O: 4.82%
H: 0.58%
C: -2.87%
growth hormone growth hormone ema application
US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency
Published: 2021-01-04 (Crawled : 14:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.16%
H: 0.19%
C: -0.16%
OPK | $1.23 0.0% 2.7M
|
Health Technology
|
| O: 2.03%
H: 7.19%
C: 4.22%
growth fda submission growth hormone hormone fda acceptance
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.